Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer.

about

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q55504441

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer.

@en

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer.

@nl

type

Item

label

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer.

@en

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer.

@nl

prefLabel

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer.

@en

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer.

@nl

P1476

Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer

@en

P2093

Alfiah Noor

http://www.w3.org/2001/XMLSchema#string

Elly De Vlieghere

http://www.w3.org/2001/XMLSchema#string

Erik Teugels

http://www.w3.org/2001/XMLSchema#string

Ijeoma Adaku Umelo

http://www.w3.org/2001/XMLSchema#string

Jacques De Grève

http://www.w3.org/2001/XMLSchema#string

Olivier De Wever

http://www.w3.org/2001/XMLSchema#string

Peter Kronenberger

http://www.w3.org/2001/XMLSchema#string

P2860

X-linked IAP is a direct inhibitor of cell-death proteases

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

An endotoxin-induced serum factor that causes necrosis of tumors

A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene

Getting TRAIL back on track for cancer therapy

BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity

Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Drug combination studies and their synergy quantification using the Chou-Talalay method

Stattic: a small-molecule inhibitor of STAT3 activation and dimerization.

P304

28731-28744

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25618

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Giron

P577

2018-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29983892

http://www.w3.org/2001/XMLSchema#string

P932

6033352

http://www.w3.org/2001/XMLSchema#string